[Vaccination perspective against human papillomavirus and consequences for the screening of uterine cervical neoplasm].
The link between cervical cancer and some types of human papillomavirus (HPV) has generated, in recent years, a great interest for the development of anti-HPV vaccines. The purpose of this article is to review the current perspectives for anti-HPV prophylactic vaccination and to describe the potential implications for the cervical cytology screening programs.
Delvenne
Ph
P
Département d'Anatomie Pathologique, CRCE, B35-C.H.U. Sart Tilman, U.Lg.
D005260:Female; D052162:Human papillomavirus 16 / Q000276:immunology; D052161:Human papillomavirus 18 / Q000276:immunology; D006801:Humans; D008403:Mass Screening; D030361:Papillomavirus Infections / Q000175:diagnosis / Q000276:immunology / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000008:administration & dosage*; D019057:Quality-Adjusted Life Years; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis / Q000276:immunology / Q000517:prevention & control* / Q000821:virology; D014611:Vaccination
D053918:Papillomavirus Vaccines